Page last updated: 2024-08-17

tetrabenazine and Pituitary Neoplasms

tetrabenazine has been researched along with Pituitary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cronin, MJ; Harcus, CT; Login, IS; MacLeod, RM1
Cronin, MJ; Login, IS; MacLeod, RM1

Other Studies

2 other study(ies) available for tetrabenazine and Pituitary Neoplasms

ArticleYear
Neuroendocrine evidence that tetrabenazine is a dopamine antagonist.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1983, Volume: 172, Issue:2

    Topics: Animals; Binding, Competitive; Cell Line; Cell Membrane; Corpus Striatum; Dopamine; Dopamine Antagonists; Kinetics; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitary Neoplasms; Rats; Receptors, Dopamine; Swine; Tetrabenazine

1983
Tetrabenazine has properties of a dopamine receptor antagonist.
    Annals of neurology, 1982, Volume: 12, Issue:3

    Topics: Animals; Binding, Competitive; Corpus Striatum; Female; In Vitro Techniques; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Tetrabenazine

1982